Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Paul Goodwyn

Orthopaedic Surgery Scottsdale, AZ Medical Doctor

NPI 1366838666 CMS profile 2781415

3126 N Civic Center Plz, Scottsdale, AZ 85251

Open in the dashboard

General payments

$56,329

227 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Paul Goodwyn of Scottsdale, AZ is reported in the CMS Open Payments database as having received $56,329 across 227 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,456 16
2024 General $25,302 49
2023 General $16,930 83
2022 General $6,336 31
2021 General $6,166 44
2020 General $138 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Goodwyn
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Paul Goodwyn were reported at $1,456. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Paul Goodwyn Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $138 $312 $75–$1,860 $114
2021 $6,166 $520 $117–$2,495 $132
2022 $6,336 $598 $128–$2,731 $149
2023 $16,930 $461 $128–$2,264 $160
2024 $25,302 $497 $134–$2,475 $164
2025 $1,456 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Globus Medical, Inc. $45,217 61 payments
  2. Stryker Corporation $3,504 50 payments
  3. OsteoCentric Technologies, Inc. $2,846 11 payments
  4. Smith+Nephew, Inc. $1,723 32 payments
  5. Arthrex, Inc. $584 1 payment
  6. Djo, LLC $396 10 payments
  7. Zimmer Biomet Holdings, Inc. $376 5 payments
  8. DePuy Synthes Sales Inc. $307 8 payments
  9. Acera Surgical, Inc. $304 16 payments
  10. Skeletal Dynamics Inc $254 4 payments
  11. Other $817 29 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Consulting Fee $28,150 6 payments
  2. Travel and Lodging $10,002 30 payments
  3. Food and Beverage $9,377 189 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,800 2 payments
Products named General payments · program years 2020–2025
  1. Autobahn $14,060 12 payments
  2. Ankle Fracture System $10,311 10 payments
  3. ANTHEM $4,093 3 payments
  4. OsteoCentric 4.0 x 130mm LOCKING BONE SCREW FASTENER ST $2,846 11 payments
  5. Cortical Screws $1,907 1 payment
  6. Clavical Fixation (16-186) $1,907 1 payment
  7. Troch Nail $876 2 payments
  8. PRO $717 2 payments
  9. EVOS $708 12 payments
  10. T2 $476 5 payments
  11. Other $10,087 207 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

112

Median for Orthopedic Surgery: 203

Drug cost

$937

Median for Orthopedic Surgery: $1,433

Branded share of claims

47.3%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 29 $344
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 24 $224
Oxycodone Hcl Generic 22 $161
Gabapentin Generic 13 $108
Meloxicam Generic 24 $100

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 111 billing codes

Paid by Medicare

$140,027

Medicare's payments for the services billed

Medicare patients

167

Average age 79

Services billed

440

121 women, 46 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Osteoporosis 46%
Depression 41%
Ischemic heart disease 36%
Chronic kidney disease 36%
Diabetes 35%
Heart failure 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

227 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record